What is the rationale for androgen therapy for women?

Treatments in Endocrinology

Volumn 2, Issue 2, 2003, Pages 77-84

  Papalia, Mary Anne ^a   Davis, Susan R ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTRATEST; ESTROGEN; NANDROLONE DECANOATE; PRASTERONE SULFATE; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ACNE; ADRENAL INSUFFICIENCY; ALOPECIA; ANDROGEN BLOOD LEVEL; ANDROGEN RELEASE; ANDROGEN THERAPY; BONE DENSITY; BONE MINERAL; CONCENTRATION RESPONSE; DIFFERENTIAL DIAGNOSIS; DRUG SAFETY; EMOTIONAL STRESS; EPIDEMIOLOGICAL DATA; ESTROGEN SYNTHESIS; FEMALE; FEMALE ANDROGEN INSUFFICIENCY; HAIR GROWTH; HORMONE DEFICIENCY; HUMAN; HYPOPITUITARISM; LACTATION; LARYNX DISORDER; LIBIDO DISORDER; LONG TERM CARE; MENOPAUSE; MOOD DISORDER; OPTIMAL DRUG DOSE; OVARY FUNCTION; PRACTICE GUIDELINE; PREGNANCY; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PROTEIN BINDING; PSYCHOLOGICAL ASPECT; QUANTITATIVE ASSAY; REPRODUCTION; REVIEW; SYMPTOMATOLOGY; TESTOSTERONE RELEASE; TREATMENT CONTRAINDICATION; VIRILIZATION; WELLBEING;

AFFECT; ANDROGENS; DEHYDROEPIANDROSTERONE SULFATE; DIAGNOSIS, DIFFERENTIAL; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIBIDO; MENOPAUSE; RISK FACTORS; TESTOSTERONE;

EID: 0041357081     PISSN: 11756349     EISSN: None     Source Type: Journal    
DOI: 10.2165/00024677-200302020-00001     Document Type: Review

References (79)

1. Bachmann GA, Bancroft J, Braunstein G, et al. Female androgen insufficiency: the Princeton consensus statement on definition, classification and assessment. Fertil Steril 2002 Apr; 77 (4): 660-5
2. Davis SR. Androgen replacement in women: a commentary. J Clin Endocrinol Metab 1999; 84 (6): 1886-91
3. Haning JRV, Hackett R, Flood CA, et al. Plasma dehydroepiandrosterone sulfate serves as a prehormone for 48% of follicular fluid testosterone during treatment with menotropins. J Clin Endocrinol Metab 1993; 76: 1301-7
4. Vierhapper H, Nowotny P, Waldhausl W. Determination of testosterone production rates in men and women using stable isotope'dilution and mass spectromety. J Clin Endocrinol Metab 1997; 82: 1492-6
5. Labrie F, Belanger A, Cusan L, et al. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab 1997; 82 (8): 2403-9
6. Rannevik G, Jeppsson S, Johnell O. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 1986; 8: 189-96
7. Judd HL, Judd G, Lucas WE, et al. Endocrine function of the postmenopausal ovary: concentrations of androgens and estrogens in ovarian and peripheral venous blood. J Clin Endocrinol 1974; 39: 1020-5
8. Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab 2000; 85 (2): 645-51
9. Zumoff B, Strain GW, Miller LK, et al. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995; 80: 1429-30
10. Burger HG, Dudley EC, Hopper DL. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 1995; 80: 3537-45
11. Labrie F, Belanger A, Cusan L, et al. Marked decline in serum concentrations of adrenal c19 sex steroid precursors and conjugated andrgoen metaboliltes during aging. J Clin Endocrinol Metab 1997; 82 (8): 2396-402
12. Couzinet B, Meduri G, Lecce M, et al. The post menopausal ovary is not a major androgen producing gland. J Clin Endocrinol Metab 2001; 86: 5060-5
13. Lasley B, Santoro N, Randolf J, et al. The relationship of circulating dehydroepiandrosterone, testosterone and estradiol to stages of the menopausal transition and ethnicity. J Clin Endocrinol Metab 2002; 87: 3760-7
14. Avis N, Crawford S, Stellato R, et al. Longitudinal study of hormone levels and depression among women transitioning through menopause. Climacteric 2001; 4 (3): 241-9
15. Sarrel P. Sexuality and the menopause. Obstet Gynecol 1990; 75 (4): 26S-30S
16. Goldstat R, Briganti E, Tran J, et al. Transdermal testosterone improves mood, well being and sexual function in premenopausal women. Menopause. In press
17. Judd HL, Lucas WE, Yen SSC. Effect of oopherectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 1994; 118 (6): 793-8
18. Nathorst-Boos J, von Schoultz H. Psychological reactions and sexual life after hysterectomy with and without oophorectomy. Gynecol Obstet Invest 1992; 34: 97-101
19. Janson P, Janson I. The acute effect of hysterectomy on ovarian blood flow. Am J Obstet Gynecol 1977; 127 (4): 349-52
20. Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 1974; 39: 340-6
21. Miller K, Sesmilo G, Schiller A, et al. Androgen deficiency in women with hypopituitarism. J Clin Endocrinol Metab 2001; 86 (2): 561-7
22. Doldi N, Belvisi L, Bassan M, et al. Premature ovarian failure: steroid synthesis and autoimmunity. Gynecol Endocrinol 1998; 12 (1): 23-8
23. Miller K, Corcoran C, Armstrong C, et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 1998; 83: 2717-25
24. van Vollenhoven RF, Morabito LM, Engleman EG, et al. Treatment of systemic lupus erythematosus with dehydroepiandrosterone: 50 patients treated up to 12 months. J Rheumatol 1998; 25 (2): 285-9
25. Booij A, Biewenga-Booij CM, Huber-Bruning O, et al. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 1996; 55: 811-86
26. Mathur RS, Landgreve SC, Moody LO, et al. The effect of estrogen treatment on plasma concentrations of steroid hormones, gonadotropins, prolactin and sex hormone-binding globulin in post-menopausal women. Maturitas 1985; 7: 129-33
27. Barrett-Connor E, Von Muhlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 1999; 84 (2): 573-7
28. Yesavage J. Plasma testosterone levels: depression, sexuality and age. Biol Psychiatry 1985; 20: 199-228
29. Rubin R. Sex steroid hormone dynamics in endogenous depression: a review. Int J Mental Health 1981; 10: 43-59
30. Grinspoon S, Corcoran C, Stanley T, et al. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 2000; 85 (1): 60-5
31. Wang C, Berman N, Longstreth J, et al. Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites. A General Clinical Research Center Study. J. Clin Endocrinol Metab 2000; 85 (3): 964-9
32. Sherwin BB. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 1988; 14 (2): 177-87
33. Shifren JL, Braunstein G, Simon J, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343 (10): 682-8
34. Burger HG, Hailes J, Nelson J, et al. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. BMJ 1987; 294: 936-7
35. Montgomery J, Brincat M, Appleby L, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; 1: 297-9
36. Brincat M, Studd JWW, O'Dowd T, et al. Subcutaneous hormone implants for the control of climacteric symptoms. Lancet 1984; 1: 16-8
37. Morales AJ, Nolan JJ Nelson JC, et al. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1997; 78: 1360-7
38. Labrie F, Diamond P, Cusan L, et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women. J Clin Endocrinol Metab 1997; 82 (10): 3498-505
39. Arlt W. Callies F, Van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 1999; 341 (14): 1013-20
40. Johannsson G, Burman P, Wiren L, et al. Low dose dehydroepiandrosterone affects behavior in hypopitnitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 2002; 87 (5): 2046-52.
41. Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, et al. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 1999; 84 (5): 1527-33
42. Dennerstein L, Smith A, Morse, et al. Sexuality and the menopause. J Psychsom Obstet Gynecol 1994; 15: 56-9
43. Dennerstein L, Dudley EC, Hopper DL, et al. Sexuality, hormones and the menopausal transition. Maturitas 1997; 26 (2): 83-93
44. Frock J, Money J. Sexuality and the menopause. Psychother Psychosom 1992; 57: 29-33
45. McCoy NL, Davidson JM. A longitudinal study of the effects of menopause on sexuality. Maturitas 1985; 7: 203-10
46. Bixo M, Backstrom T, Winblad B, et al. Estradiol and testosterone in specific regions of the human female brain in different endocrine states. J Steroid Biochem Mol Biol 1995; 55: 297-303.
47. Ogawa S, Chester AE, Hewitt SC, et al. Abolition of male sexual behaviours in mice lacking estrogen receptors alpha and beta. Proc Natl Acad Sci 2000; 97 (26): 14737-41
48. Simpson ER, Rubin G, Clyne C, et al. The role of local estrogen biosynthesis in males and females. Trends Endocrinol Metab 2000; 11 (5): 184-8
49. Utian WH. The true clinical features of postmenopausal oophorectomy and their response to estrogen replacement therapy. S Afr Med J 1972; 46: 732-7
50. Campbell S, Whitehead M. Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynecol 1977; 4: 31-47
51. Studd JWW, Chakravarti S, Oram D. The climacteric. Clin Obstet Gynecol 1977; 4: 3-29
52. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987; 49 (4): 397-409
53. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy: sexual behaviour and neuroendocrine response. J Reprod Med 1998; 43: 847-56
54. Davis SR, McCloud PI, Strauss BJG, et al. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227-36
55. Studd JWW, Colins WP, Chakravarti S. Estradiol and testosterone implants in the treatment of psychosexual problems in postmenopausal women. Br J Obstet Gynaecol 1977; 84: 314-5
56. Burger HG, Hailes J, Menelaus M. The management of persistent symptoms with estradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas 1984; 6: 351-8
57. Davis SR, Walker KZ, Strauss BJ. Effects of estradiol with and without testosterone on body composition and relationships with lipids in post-menopausal women. Menopause 2000; 7: 395-401
58. Tuiten A, Von Honk J, Koppeschaar H, et al. Time course ofeffects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000; 57: 149-53
59. Tuiten A, Laan E, Panhuysen G, et al. Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychosom Med 1996; 58: 234-41
60. Abu EO, Horner V, Kusec V, et al. The localization of androgen receptors in human bone. J Clin Endocrinol Metab 1997; 82 (10): 3493-7
61. Morishima A, Grumbach MM, Simpson ER. Aromatase deficiency in male and female siblings caused by a novel mutuation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80: 3689-98
62. Buchanan JR, Hospodar P, Myers C, et al. Effect of excess endogenous androgens on bone density in young women. J Clin Endocrinol Metab 1988; 67 (5): 937-43
63. Gregoriou O, Kouskouni E, Bakas P, et al. Bone mineral density in women with idiopathic hirsutism. Gynecol Endocrinol 2000; 14: 364-8
64. Dicarlo C, Shoham Z, MacDougall J, et al. Polycystic ovaries as a relative protective factor for bone mineral loss in young women with amenorrhea. Fertil Steril 1992; 57 (2): 314-9
65. Davidson BJ, Ross RK, Paganini-Hill A, et al. Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 1982; 54 (1): 115-20
66. Jassal SK, Barrett-Connor E, Edelstein S. Low bioavailable testosterone levels predict future height loss in postmenopausal women. J Bone Miner Res 1995; 10 (4): 650-3
67. Cummings SR, Browner WS, Bauer DC, et al. Endogenous hormones and the risk of hip and vertebral fractures among older women: Study of Osteoporotic Fractures Research Group. N Engl J Med 1998; 339 (11): 733-8
68. Watts NB, Notelovitz M, Timmons MC. Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms and lipid-lipoprotein profiles in surgical menopause. Obstet Gynecol 1995; 85: 529-37
69. Barrett-Connor E, Young R, Notelovitz M, et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women: effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999; 44 (12): 1012-20
70. Savvas M, Studd JWW, Norman S, et al. Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post menopausal women who have previously received long-term oral oestrogens. Br J Obstet Gynaecol 1992; 99: 757-60
71. Raisz LG, Witta B, Artis A, et al. Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 1995; 81: 37-43
72. Worboys S, Kotsopoulos D, Teede H, et al. Parental testosterone improves endothelium-dependent and independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 2001; 86 (1): 158-61
73. Yue P, Chatterjee K, Beales CM, et al. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 1995; 91: 1154-60
74. Bernini G, Sgro M, Moretti A. Endogenous androgens and carotid intimal-medial thickness in women. J Clin Endocrinol Metab 1999; 84: 2008-12
75. Zhou J, Ng S, Adesanya-Famuiya O, et al. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 2000 Sep; 14 (12): 1725-30
76. Dimitrakakis C, Zhou J, Bondy CA. Androgens and mammary growth and neoplasia. Fertil Steril 2002; 77 (4): S26-s33
77. Davis SR, Tran J. Testosterone influences libido and wellbeing. Trends Endocrinol Metab 2001; 12 (1): 33-7
78. Slater C, Souter I, Zhang C, et al. Pharmacokinetics of testosterone after percutaneous gel or buccal administration. Fertil Steril 2001; 76 (1): 32-7
79. Writing Group for Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-33